Two protein forms of tyrosine phosphatase epsilon (PTPe) are known ± receptor-like (tm-PTPe) and non receptor-like (cyt-PTPe), with each form possessing unique tissue-speci®c expression patterns, subcellular localization, and physiological functions. We describe two additional forms of PTPe protein ± p67 and p65. p67 is produced by initiation of translation at an internal initiation codon of PTPe mRNA molecules, while p65 is produced by speci®c proteolytic cleavage of larger PTPe proteins. Cleavage is inhibited by MG132, but is proteasome-independent. In contrast with full-length tm-PTPe and cyt-PTPe, p67 and p65 are exclusively cytoplasmic, are not phosphorylated by Neu, and do not associate with Grb2 in unstimulated cells. p67 and p65 are catalytically active and can reduce Src-mediated phosphorylation of the Kv2.1 voltage-gated potassium channel, albeit with reduced eciency which most likely results from their cytoplasmic localization. We also show that full-length cyt-PTPe protein can be found at the cell membrane and in the nucleus and that it is the ®rst 27 residues of cyt-PTPe which determine this localization. p67 and p65 provide mechanisms for removing PTPe activity from the cell membrane, possibly serving to down-regulate PTPe activity there. PTPe emerges as a family of four related proteins whose expression, subcellular localization and most likely physiological roles are subject to complex regulation at the transcriptional, translational and post-translational levels.
Introduction
Accurate phosphorylation of tyrosine residues in proteins is vital for the well-being of cells and organisms, and is a process closely regulated by opposing activities of protein tyrosine kinases and tyrosine phosphatases (Hunter, 1995) . Because they are genetically, structurally, and functionally distinct from tyrosine kinases, tyrosine phosphatases (PTPases) oer a unique vantage point from which to study regulation of biological processes by tyrosine phosphorylation. In recent years it has become evident that subcellular localization of non-membranal PTPases is an important factor in determining their physiological roles (reviewed in Mauro and Dixon, 1994; Fischer, 1999) . Along these lines, SHP1 and SHP2 can be recruited, via their SH2 domains, to activated growth factor receptors (Stein-Gerlach et al., 1998) , while several other non-membranal PTPases possess protein motifs which allow them to associate with cytoskeletal or membranal proteins. Several cytoplasmic phosphatases, such as PTP1B, PTP-PEST, and STEP, can undergo proteolytic cleavage, which alters their subcellular localization and can result in their activation (Frangioni et al., 1993; Gu and Majerus, 1996; Gurd et al., 1999; Nguyen et al., 1999) . In general, subcellular localization of a PTPase can in¯uence its physiological function by determining the repertoire of potential substrates and interactors available to the enzyme.
PTPe, which is at the focus of this study, was originally cloned as a transmembranal, receptor-type PTPase (tm-PTPe; Krueger et al., 1990) . A second form of PTPe, one which is not an integral membrane protein, was subsequently identi®ed (cyt-PTPe; Elson and Leder, 1995a; Nakamura et al., 1996) . cyt-PTPe and tm-PTPe are identical throughout most of their sequence, including their two catalytic domains; their N-termini are, however, entirely distinct from one another, a fact which determines their unique subcellular localizations. tm-PTPe and cyt-PTPe are products of distinct mRNA species transcribed from the single PTPe gene by use of alternative promoters; the two proteins have virtually non-overlapping expression patterns in cells and among tissues, suggesting that they play distinct physiological roles (Elson and Leder, 1995a; Elson et al., 1996; Tanuma et al., 1999) . As the catalytic domains of tm-PTPe and cyt-PTPe are identical, their distinct roles are believed to result from their dierent expression patterns.
Along these lines, we have shown that tm-PTPe, but not cyt-PTPe, is expressed in mouse mammary tumors initiated speci®cally by ras or neu, but not by myc, int-2, TGF-a, or heregulin (Elson and Leder, 1995b) . This ®nding suggests that tm-PTPe may participate in molecular processes by which ras or neu speci®cally transform mammary epithelium. In agreement with this interpretation, overexpression of tm-PTPe in mouse mammary epithelium promotes mammary hyperplasia and associated neoplasia . tm-PTPe can down-regulate insulin receptor signaling in certain types of cultured cells (Moller et al., 1995) , a function which is not shared with cyt-PTPe due to the predominantly non-membrane localization of the latter (JN Andersen, A Elson, R Lammers, J Romer, JT Clausen, KB Moller and NPH Moller, manuscript submitted for publication). We have recently shown that cyt-PTPe is a regulator of myelination of peripheral nerves in vivo, a function most likely mediated by the ability of the phosphatase to dephosphorylate and inactivate voltage-gated potassium channels present in Schwann cells (Peretz et al., in press) .
In this study we describe two additional forms of the PTPe protein, p67 and p65. p67 is produced by initiation of translation from an internal AUG codon present in mRNAs for tm-PTPe or cyt-PTPe; p65 is produced in vivo from tm-PTPe, cyt-PTPe, or p67 proteins by proteolytic processing. p67 and p65 are cytoplasmic molecules and dier in this respect from tm-PTPe and cyt-PTPe. p67 and p65 are catalytically active and can reduce Src-mediated phosphorylation of voltage-gated potassium channels in cells, albeit somewhat less eciently than the full-length PTPe forms. In contrast with full-length PTPe, p67 and p65 are not phosphorylated following co-expression with Neu and do not associate with the adaptor protein Grb2 in unstimulated cells, demonstrating that subcellular localization controls the ability of PTPe to associate with other molecules. PTPe therefore emerges as a family of four related proteins whose properties and subcellular localization patterns are subject to complex regulation.
Results

p67 and p65 proteins are products of the PTPe gene
Examination of PTPe expression in various cell lines and mouse tissues consistently revealed two unidenti®ed protein bands of approximately 67 and 65 kDa molecular mass (Figure 1a ). Both proteins were PTPederived as they appeared together with either tm-PTPe or cyt-PTPe in cells transfected with full-length PTPe cDNA constructs (Figure 1b) , and, together with tmPTPe or cyt-PTPe, were not detected in tissues of genetargeted, PTPe-de®cient mice ( Figure 1c ; Peretz et al., in press ). Treatment of growing cells or of cell lysates with sodium pervanadate or with alkaline phosphatase did not aect amounts of p67 and p65 (not shown), indicating that both proteins were not phosphorylation state isoforms of one another, nor of tm-PTPe or cytPTPe. Addition of a FLAG-tag at the carboxy termini of full-length tm-PTPe or cyt-PTPe molecules resulted in appearance of similarly tagged p67 and p65, indicating that the C-termini of both proteins were identical with those of the full length forms ( Figure  1d ). tm-PTPe and cyt-PTPe dier only at their amino termini (Elson and Leder, 1995a) . Detection of the same p67 and p65 proteins together with either tmPTPe or cyt-PTPe suggested therefore that p67 and p65 lack the unique amino termini of either form of fulllength PTPe.
p67 is produced by translation initiation at an internal ATG codon PTPe cDNA sequences contain four in-frame ATG or CTG codons downstream of the initiator ATG (ATG1) codons of either tm-PTPe or cyt-PTPe (Figure 2 ). These downstream codons are located in the region common to both PTPe species; initiation of translation at any of them could generate proteins of 65 ± 68 kDa ( Figure 2 ). The four codons include two ATG codons located 48 and 90 nucleotides downstream of the point where the sequences of tm-PTPe and cyt-PTPe converge (ATG2, ATG3), and two CTG codons located immediately following ATG3 (CTG1, CTG2). All four codons are embedded in sub-optimal Kozak consensus sequences (Kozak, 1987 (Kozak, ,1997 and are conserved in mouse and man.
In order to determine whether initiation of translation at any of these codons could give rise to p67 or p65, we constructed a series of PTPe cDNA molecules in which ATG1, ATG2, and ATG3 codons were inactivated either separately or in various combinations (Figure 3 ). Codons were inactivated by mutating them to CTT, which replaces methionine with leucine in the resulting protein. Inactivation of ATG1 codons in either tm-PTPe or cyt-PTPe resulted in disappearance of full-length PTPe protein molecules, together with increased accumulation of p67; expression of p65 was largely unaected (Figure 3b and c, D1 lane). These results con®rm that ATG1 codons govern expression of full-length tm-and cyt-PTPe molecules (Elson and Leder, 1995a,b) . Mutation of the ATG2 codon completely abolished expression of p67 (Figure 3b and c, D2 lane); together with increased expression of p67 upon inactivation of ATG1, this ®nding indicates that p67 is the product of translation initiation at ATG2, most likely by ribosomes which fail to initiate translation at ATG1.
p65 is not the product of internal initiation of translation
In contrast, inactivation of the ATG3 codon did not prevent detection of p65. tm-PTPe or cyt-PTPe cDNA Simultaneous point-mutating all three ATG codons in cyt-PTPe cDNA prevented detection of all forms of PTPe (not shown), indicating that presence of either full-length PTPe or p67 was required for p65 production.
Translation can on occasion initiate at CTG codons (Hann et al., 1988; Florkiewicz et al., 1989; Acland et al., 1990) . Point-mutation of the CTG1 or CTG2 codons to CTT, a change aected without altering protein sequence, did not aect p65 levels. Similar results were obtained upon point mutation of both CTG codons together with ATG3 (not shown). Together, these results indicate that p65 is not produced by initiation of translation at ATG3 or at the adjacent CTG codons.
p65 is produced by proteolytic cleavage of larger PTPe molecules
In the course of determining whether p65 was produced by proteolytic processing of larger PTPe molecules we examined the eects of MG132, a known inhibitor of proteasomes and of other proteases (Dick et al., 1996; Lee and Goldberg, 1998; Meng et al., 1999) . Cells expressing full length cyt-PTPe, p67 and p65 proteins were treated with cycloheximide to halt mRNA translation; this treatment alone did not aect amounts of the various PTPe forms during the time period examined (Figure 4 ). Following addition of MG132, amounts of full-length cyt-PTPe and p67 proteins were not aected; in contrast, p65 disappeared almost entirely from the cell lysates (Figure 4a ,c). Lactacystin (Dick et al., 1996) and Epoxomicin (Meng et al., 1999) , more speci®c inhibitors of proteasome function, did not prevent production of p65 ( Figure  4a ,b). All three inhibitors were active and entered the cells as they could inhibit degradation of ornithine decarboxylase (ODC), a process known to be mediated by proteasomes (Murakami et al., 1992; Pickart, 1997) (Figure 4a,b) . This ®nding indicates that p65 is produced by proteolytic cleavage of larger PTPe molecules in a process which is proteasome-independent.
MG132 inhibited production of p65 in cells expressing either only p67 or only full-length cyt-PTPe ( Figure 4c , D2/3 and D1/3 lanes). In a similar manner, MG132, but not Lactacystin, inhibited production of p65 from tm-PTPe ( Figure 4d ). We conclude that all three known PTPe molecules which are larger than p65 can give rise to p65 via proteolysis. The precise amino terminus of p65 has yet to be identi®ed. However, a truncated version of PTPe initiating at ATG3 (=Met42 in cyt-PTPe; marked as D1,2 in Figure 3a ) migrates similarly to p65 in SDS ± PAGE analysis, indicating that the N-terminus of p65 is located in the immediate vicinity of Met42 (not shown). Rapid disappearance of p65 from cell lysates following addition of MG132 indicates that in contrast to its production, subsequent degradation of p65 is not inhibited by MG132 and likely proceeds by a dierent mechanism. The fact that MG132 exerts its eect after being applied to living cells indicates that formation of p65 occurs in vivo and is a physiological, pre-lysis event. This conclusion is further supported by the ®nding that the physiological state of living cells can in¯uence the relative amounts of p67 and p65. As seen in Figure 4e , full-length cyt-PTPe and p67 were signi®cantly less abundant in crowded NIH3T3 cells than in sparse proliferating cells. In contrast, p65 levels were hardly reduced, allowing p65 to account for a third of PTPe molecules in crowded NIH3T3 cells (Figure 4e ). (Elson and Leder, 1995a) . (b) Nucleic acid sequences surrounding ATG1, ATG2 and ATG3 codons. Shown also are CTG1 and CTG2 codons immediately following ATG3. Codons are underlined and numbered; ATG codons are indicated also in boldface type. Shown also is the Kozak consensus sequence for translation initiation (Kozak, 1987 (Kozak, , 1997 . Genbank accession numbers of sequences used are: U36758, U35368, U36623, X54134 p67 and p65 are cytoplasmic molecules
The distinct patterns of subcellular localization of fulllength tm-PTPe and cyt-PTPe are determined by the amino termini of either molecule (Elson and Leder, 1995a) ; these regions are missing from both p67 and p65. In order to determine the subcellular localization patterns of p67 and p65 we fractionated cells expressing endogenous or transfected PTPe ( Figure  5 ). Expression of wild-type cyt-PTPe cDNA in 293 cells resulted in appearance of full length cyt-PTPe, together with both p67 and p65 (Figure 5a ). Most (*80%) fulllength cyt-PTPe molecules were found in the cytoplasmic fraction, with the remainder recovered equally from the membrane and nuclear fractions. Weak membrane localization of cyt-PTPe was noted previously in HL-60 cells (Elson and Leder, 1995a) . In contrast, expression of p67 and p65 was virtually entirely cytoplasmic (Figure 5a,b) . Similar results were obtained with cells which express endogenous cyt-PTPe, such as TPA-dierentiated HL60 or Jurkat T-cells (Figure 5a,b) .
Expression of full-length endogenous tm-PTPe also diered from that of p65 and p67 in SMF mouse mammary tumor cells; p67 and p65 were recovered mainly from the cytoplasmic fraction, while full-length tm-PTPe was found in the membrane fraction ( Figure  5c ). Low levels of p65, but not of p67, were occasionally recovered from the membrane fraction of cells expressing tm-PTPe. As full-length tm-PTPe and p67 were absent from the non-membrane and membrane fractions, respectively, this observation is not an artifact of the fractionation process. Reports that D2 domains of PTPases can bind other domains of PTPase molecules (Wallace et al., 1998; Blanchetot and den Hertog, 2000) raise the possibility that following cleavage, some p65 molecules remain associated with uncleaved full length tm-PTPe molecules and are retained at the cell membrane.
Similar ®ndings were obtained independently by immuno¯uorescence microscopy ( Figure 6 ). Upon expression of wild-type cyt-cDNA in 293 cells, staining was clearly evident at the cell membrane, in the cytoplasm, and in the nucleus (Figure 6 , WT). Identical results were obtained upon analysis of cells expressing the DATG2/3 mutant of cyt-PTPe, which drives expression of full-length cyt-PTPe without any accompanying p67 ( Figure 6 , D2/3). In contrast, expression of p67 without accompanying full-length cyt-PTPe (Figure 6 , D1/3) resulted in staining which was exclusively cytoplasmic. No membrane or nuclear staining was detected in the course of examining transfected cells at various focal planes with the aid of a confocal microscope. These data indicate that sequences N-terminal to Met28 (corresponding to ATG2) in cyt-PTPe drive membrane association and nuclear localization of a sub-population of cyt-PTPe molecules.
p67 and p65 can inhibit Src-mediated phosphorylation of Kv2.1
Expression of wild-type cyt-PTPe in cells severely inhibits Src-or Fyn-mediated phosphorylation of voltage-gated potassium (Kv) channels and downregulates channel activity in vivo and in vitro. This eect is dependent upon PTPe catalytic activity and is mediated at least in part by PTPe dephosphorylating Kv channel a-subunits, thus providing a physiologically-relevant and convenient in-vivo indication of PTPe activity (Peretz et al., in press ). Expression of full-length cyt-PTPe in 293 cells, either with or without accompanying p67 and p65, resulted in nearly total dephosphorylation of the Kv2.1 potassium channel a-subunit (Figure 7 , lanes WT and D 2/3), a ®nding previously shown to correlate with downregulation of Kv2.1 channel activity (Peretz et al., in press ). Expression of p67 or of the D 1,2 truncated PTPe molecule described above, which is similar in mass to p65, caused dephosphorylation of Kv2.1, although the eect was approximately twofold weaker than observed with full-length cyt-PTPe (Figure 7 , lanes D1/3, D1/2). In a separate set of experiments, tm-PTPe, cyt-PTPe, p67, or D1,2 truncated PTPe were separately expressed in 293 cells and were found to be similarly active towards paranitrophenylphosphate (not shown). As they appear to possess similar inherent catalytic activity, we interpret the above results as arising from the absence of p67 and p65 from the cell membrane. Association with the cell membrane is therefore an important, although not exclusive, determinant in allowing PTPe to dephosphorylate the integral membrane protein Kv2.1.
Subcellular localization affects molecular associations of PTPe
In order to determine whether their unique pattern of subcellular localization could determine the identity of molecules with which p67 and p65 interact, we examined the ability of all forms of PTPe to be phosphorylated when co-expressed with the integral membrane tyrosine kinase Neu. As seen in Figure 8a , Neu-induced tyrosine phosphorylation was detected only in full-length cyt-PTPe, while both p67 and p65 remained unphosphorylated. The N-terminal amino acid residues of full-length cyt-PTPe which are missing from p67 and from p65 do not contain any tyrosine residues (Figure 2a) , indicating that decreased phosphorylation was not due to loss of phosphorylation sites. In agreement with these results, expression of p67 and p65 in the absence of full-length cyt-PTPe did not result in tyrosine phosphorylation of either protein, despite higher levels of p67 present in these experiments (Figure 8a) . Similar results were obtained with Figure 4 MG132 inhibits production of p65. 293 cells were transfected with wild-type cyt-PTPe or ODC cDNAs and treated with cycloheximide (CHX), and either DMSO vehicle, MG132, or Lactacystin (a), or Epoxomicin (b). Treated cells were lysed 2 h later; lysates were analysed by protein blotting using anti-PTPe or anti-ODC antisera. Note disappearance of p65 (marked by an asterisk) from samples treated with MG132. (c) p65 can be produced from either full-length cyt-PTPe or p67. Cells were transfected with WT cyt-PTPe cDNA or with mutant cDNA molecules which contain only functional ATG1 (D2/3) or ATG2 codons (D1/3). MG132 treatment inhibited production of p65 in either case. (d) p65 can be produced from tm-PTPe. Experiment similar to (a) performed in 293 cells expressing DATG3 tm-PTPe. Similar results were obtained also with wild-type tm-PTPe (not shown). (e) NIH3T3 cells were plated at various densities in 9 cm plates and harvested 48 h later. Following protein blot analysis (top), amounts of PTPe expressed at each density were quanti®ed with the aid of a scanning densitometer (bottom) Figure 5 Subcellular localization of the various PTPe proteins. 293 cells transfected with WT cyt-PTPe cDNA, TPA-dierentiated HL60 cells, Jurkat T-cells, or SMF mammary tumor cells were fractionated into cytosolic (S100) and membranal (P100) fractions (a,c), or into membranal plus cytosolic (M&C) vs nuclear (Nuc.) fractions (b). Fractions were analyzed by protein blotting and probed with anti-PTPe antiserum. Note that similar levels of full-length cyt-PTPe and p67 are found in most samples; yet only cyt-PTPe, but not p67 or p65, is detected in nuclear and membranal fractions. Asterisk (a) indicates P100 panel intentionally overexposed Figure 6 p67 and p65 are cytoplasmic proteins. 293 cells were transfected with FLAG-tagged PTPe cDNAs which were either wildtype (WT), contained only an intact ATG1 codon (DATG2/3), or only an intact ATG2 codon (DATG1/3). Cells were stained with anti-FLAG antibodies. Note staining at membrane (M) and in the cytoplasm (C) and nucleus (N) in (a and b) compared with lack of membrane and nuclear staining in (c). Localization as in c was observed in cells expressing a PTPe molecule whose translation starts at the ATG3 codon and which is similar in mass to p65 (not shown) In a separate series of experiments we examined associations between PTPe and the adaptor molecule Grb2. Grb2 binds either tm-PTPe or cyt-PTPe molecules via its SH2 domain in an interaction which requires tyrosine phosphorylation of PTPe (Toledano-Katchalski and . This association can be detected in several cell types due to basal phosphorylation of PTPe by resident tyrosine kinases. Human HL60 cells express similar levels of endogenous cyt-PTPe and p67 following dierentiation with phorbol 12-myristate, 13-acetate (TPA; Elson and Leder, 1995a;  Figure 8c ). However, pulldown experiments using a glutathione-S-transferase (GST)-Grb2 fusion protein revealed that full-length cytPTPe, but not p67, associates with GST-Grb2 (Figure  8c ), most likely re¯ecting dierent levels of basal tyrosine phosphorylation of both forms of PTPe in freelygrowing, unstimulated HL60 cells. In agreement with this interpretation, strong stimulation of cellular tyrosine phosphorylation by sodium pervanadate resulted in similar levels of association of both cyt-PTPe and p67 with GST-Grb2, indicating that lack of N-terminal sequences did not remove sequences required for binding of p67 to Grb2 (Figure 8c ). Preferred basal association of full-length cyt-PTPe, but not p67 nor p65, with endogenous Grb2 was observed also in 293 cells transfected with wild-type cyt-PTPe cDNA and which were not stimulated with sodium pervanadate (Toledano-Katchalski and Elson, 1999 ; and results not shown). Their subcellular expression pattern therefore aects the repertoire of molecules with which p67 and p65 interact.
Discussion
The two additional forms of PTPe described here, p67 and p65, raise the number of known PTPe proteins to four. The general scheme by which expression of members of the PTPe family is regulated is summarized in Figure 9 . Details of this scheme broaden the scope of processes which regulate PTPe expression and subcellular localization to include translational and post-translational events.
Post-translational regulation of PTPe expression is evident in p65, which is the product of speci®c, in vivo cleavage of full length tm-PTPe, cyt-PTPe, or p67. Cleavage occurs in close proximity to, but appears to be independent of, Met42 (numbered as in cyt-PTPe; corresponds to the ATG3 codon). Interestingly, cleavage is inhibited by MG132 but not by Lactacystin or Epoxomicin. All three reagents inhibit protein degradation by proteasomes, although MG132 is least speci®c of the three and is known to inhibit additional proteases, such as lysosomal and Ca 2+ -regulated proteases. The data implicate one of these proteases, rather than proteasomes, in production of p65. In particular, calpain has been described to prefer leucine or valine residues as the second residue on the Nterminal site of cleavage (Wang and Yuen, 1994) ; in agreement, Met 42 is indeed preceded by a valine residue and is followed by two consecutive leucine residues. Of note, p65 is consistently absent from the hematopoietic cell lines examined, HL60 and Jurkat, re¯ecting absence or inactivity of the protease involved. Finally, the data also clearly demonstrate the dierent in vivo eects of MG132 and Lactacystin, two reagents which are widely and often interchangeably used as proteasome inhibitors in studies of protein degradation.
Data presented here indicate that it is the 27 amino terminal-most amino acids of full-length cyt-PTPe which allow association of this protein with the cell Figure 8 Subcellular localization aects molecular associations of PTPe. (a) 293 cells were transfected with cDNAs encoding Neu, wild-type (WT) or D1/3 mutants of cyt-PTPe or combinations thereof as indicated. Top: PTPe was immune-precipitated via its FLAG tag; PTPe phosphorylation was assessed by protein blot analysis using anti-phosphotyrosine antibodies; lane at extreme right (marked by an asterisk) contains crude lysate to indicate positions of cyt-PTPe, p67, and p65. Note that only full-length cytPTPe is phosphorylated. Middle and bottom panels verify immuneprecipitation of PTPe, and expression of Neu in the transfected cells. (b) Similar experiment as in a, using tm-PTPe cDNAs. Lane at extreme right (marked by an asterisk) indicates migration of various forms of tm-PTPe. Glyc., Unglyc. ± glycosylated and unglycosylated forms of tm-PTPe, respectively. (c) HL60 cells were dierentiated for 24 h with TPA (Elson and Leder, 1995a) , after which some cells were treated for 10 min with 0.15 mM sodium pervanadate (Van). Lysates were incubated with beads coated with GST-Grb2, and amounts of associated PTPe were analysed by protein blotting with anti-PTPe antiserum (top panel). Middle and bottom panels document expression of cyt-PTPe in HL60 lysates and recovery of GST-Grb2 protein from the lysates, respectively membrane and nucleus. Examination of this sequence reveals three protein motifs which could function as nuclear localization signals ± R 4 K, R 14 KQRK and K 26 K. This region lacks obvious acylation sites or other types of motifs which could account for membrane association of cyt-PTPe. Interestingly, over 20% of the ®rst 27 residues of cyt-PTPe are serines or threonines ± six residues in mouse, eight in human cytPTPe ± raising the possibility that localization of cytPTPe could be regulated by phosphorylation of these residues.
Results presented here allow one to speculate as to the physiological signi®cance of p67 and p65. Both proteins are not minor constituents of cellular PTPe, as they are readily detected and expressed at levels which can rival those of full-length PTPe. p67 is strongly expressed in HL60 and in Jurkat cells (Figure 5 ), while p65 is as prominent as the other forms of PTPe in con¯uent NIH3T3 cells and usually also in 293 cells (Figure 4 ). p67 and p65 are functional members of the PTPe family and are catalytically active. Nonetheless, p67 and p65 dier from tm-PTPe and cyt-PTPe in their subcellular localization patterns, a factor of clear physiological importance to PTPases (Fischer, 1999) . Both p67 and p65 are cytoplasmic molecules; this contrasts with tm-PTPe, which is an integral membrane protein, and with cyt-PTPe, some of which can also be found at the cell membrane and in the nucleus. In a manner consistent with their relatively low presence at the cell membrane, p67 and p65 exhibit reduced ability to in¯uence Kv2.1 phosphorylation, a parameter known to aect Kv2.1 channel activation. p67 and p65 are also not phosphorylated following co-expression with Neu, and do not associate with Grb2 in unstimulated cells. These ®ndings suggest that a role of p67 and p65 may be to down-regulate PTPe activity by re-distributing the enzyme away from the cell membrane.
Expression of p67 and p65 in conjunction with tm-PTPe allows PTPe to be found in the cytoplasm from which full-length PTPe is absent, and physically separates PTPe catalytic domains from the trans-membranal and extracellular domains. Relatively little is known about how extracellular and transmembranal domains of receptor-type PTPases in¯uence their activity. However, membrane localization has been shown to be critical for the ability of tm-PTPe to down-regulate insulin receptor signaling in BHK cells; catalytically-active PTPe which is not membrane-associated does not aect signaling via this pathway (JN Andersen, A Elson, R Lammers, J Romer, JT Clausen, KB Moller and NPH Moller, manuscript submitted for publication). Increased expression of p67 or p65 at the expense of tm-PTPe would therefore be expected to down-regulate the eect of tm-PTPe on insulin receptor signaling in this system.
At the present time the major dierence between p67 and p65 is in the manner by which their expression is regulated. As evident from their relative expression levels in sparse vs. crowded NIH3T3 cells, expression levels of p67 and p65 can respond dierently to similar physiological cues. One cannot rule out the possibility that unique roles for p67 or p65, which arise from their similar yet distinct amino termini, will eventually come to light.
Regulation of subcellular localization of PTPases by post-translational proteolysis has been documented in a few cases. PTP1B is known to bind the endoplasmic reticulum via its 35 carboxy-terminal amino acids (Frangioni et al., 1992) . This region can be removed by calpain-mediated cleavage in platelets, resulting in two-fold activation of PTP1B and in redistribution of the enzyme in platelets in a manner correlating with transition from reversible to irreversible platelet aggregation (Frangioni et al., 1993) . Similar cleavage of PTP1B occurs in T-cells (Rock et al., 1997) . The PTPase STEP has recently been shown to undergo calcium-dependent cleavage in primary neuronal cultures in response to glutamate or to hypoxia/ischemia . The receptor-type PTPases LAR and PTPs are expressed at the cell surface as an association of two polypeptides derived from a single precursor. The membrane-bound polypeptides of either PTPase, which include a short extracellular domain and their entire cytoplasmic domains, are processed intracellularly near their amino termini (Aicher et al., 1997) . Processing results in redistribution of the now-soluble intracellular domains of these PTPases to the cytoplasm. Together with this last example, our present study broadens the concept of regulation of PTPase function by intracellular targeting, which had previously been demonstrated in non receptor-type PTPases, to include also receptortype PTPases.
Materials and methods
Cell culture
Human embryonic kidney 293 cells were grown in Dulbecco's modi®ed Eagles' medium (DMEM, Gibco), supplemented with 10% (vol/vol) fetal calf serum (FCS, Gibco); HL60 and Jurkat cells were grown in RPMI medium (Gibco)/10% FCS; SMF (Muller et al., 1988) and AC816 cells (Leder et al., 1990) were grown in DMEM supplemented with 10% ironsupplemented bovine serum (Hyclone). All media were Figure 9 Production of the four forms of PTPe. Schematic representation depicting transcription of two major mRNAs from the single PTPe gene; tm-PTPe and cyt-PTPe are each translated from one of the mRNA species, while p67 can be translated from either one. p65 is produced by in vivo proteolytic cleavage from either tm-PTPe, cyt-PTPe, or p67 supplemented with 2 mM glutamine, 50 units/ml penicillin, and 50 mg/ml streptomycin.
Eukaryotic and bacterial expression constructs
An expression construct for full-length, wild-type FLAGtagged tm-PTPe in the pCDNA3 plasmid (plasmid 8116) was constructed by adding a FLAG tag to the 3' end of the coding region of clone 58 (mouse tm-PTPe cDNA; Elson and Leder, 1995b) by PCR. The product was cut with NheI and cloned into the compatible XbaI site of pCDNA3. Plasmid 8133 (wild-type, FLAG-tagged cyt-PTPe) was constructed from plasmid 8116 by replacing all of the tmPTPe cDNA upstream of an internal EcoRI site at position 2357 (Elson and Leder, 1995b) with the analogous fragment from full-length mouse cyt-PTPe cDNA (clone 122; Elson and Leder, 1995a) . Point mutations in the ATG1, ATG2, ATG3, CTG1, or CTG2 codons, deletion of the ATG3 triplet, or combinations thereof were introduced into plasmids 8116 or 8133 by site-directed mutagenesis (Kunkel, 1985) . Presence of mutations was veri®ed by DNA sequencing.
Other plasmids used included expression vectors for rat Kv2.1 (gift of Dr M Lazdunski), chicken Y527F Src (gift of Dr S Courtneidge), and mouse ornithine decarboxylase (gift of Dr C. Kahana). Rat Neu cDNA (gift of Dr WJ Muller) was subcloned into the pCDNA3 vector and used as such. Plasmid encoding the GST-Grb2 fusion protein was a gift of Dr Jan Sap.
Immunoprecipitation and protein blot analyses
Cells or selected organs from wild-type or PTPe-de®cient mice were lysed in Buer A (50 mM Tris-Cl, pH 7.5; 100 mM NaCl; 1% NP-40), supplemented with 0.5 mM sodium pervanadate and protease inhibitors (1 mM AEBSF, 40 mM Bestatin, 15 mM E-64, 20 mM Leupeptin, 15 mM Pepstatin; Sigma); 5 ± 10 mg protein were analysed on 7% SDSpolyacrylamide gels. For immunoprecipitations, 0.5 ± 1 mg of total cell protein were reacted with the relevant antibodies and protein A-agarose beads for 3 ± 4 h, followed by three extensive washes with RIPA buer. In some experiments, GST-Grb2 fusion protein was prepared in XL1-Blue bacteria (Stratagene) and used to precipitate PTPe from cell lysates as described (Toledano-Katchalski and Elson, 1999) . Experiments were repeated 2 ± 5 times, and representative blots are shown. Primary antibodies used in this study included polyclonal anti-PTPe (Elson and Leder, 1995b) , polyclonal anti Kv2.1 (Upstate Biotechnology), monoclonal anti-v-Src (Calbiochem), anti-FLAG M2 anity beads (Sigma), monoclonal anti-ODC (Sigma, clone ODC-29), monoclonal antiErbB2 (Transduction Laboratories, clone 42), or antiphosphotyrosine (Transduction Laboratories, clone PY20).
Cell culture studies
Cells were transfected by the calcium phosphate technique (Chen and Okayama, 1987) . For proteolysis inhibition studies, freely growing cells were treated for 2 h with 20 mg/ ml cycloheximide (Sigma), together with 50 mM MG132 (Calbiochem), 30 mM Lactacystin (Calbiochem), 10 mM Epoxomicin (Aniti Research Products, UK), or dimethylsulfoxide (DMSO) vehicle (up to 1.25% vol/vol). In some experiments, cells were treated with 0.15 mM sodium pervanadate for 10 min prior to lysis (Toladano-Katchalski and Elson, 1999) . Fractionation of cells to nuclear, cytoplasmic, and membranal fractions by centrifugation or lysis by NP-40 has been described (Elson and Leder, 1995a) . In some experiments, quality of membrane/cytosolic vs. nuclear fractionation was monitored by probing blots for Src and for SOS, while S100 vs. P100 fractionation was monitored by probing blots for Ras-GAP (not shown). For immuno¯uorescence, 293 cells were plated on glass cover slips previously coated with rat tail collagen (Sigma) and transfected with the relevant expression vectors. The following day cells were washed in phosphate-buered saline, ®xed for 15 min in 3% paraformaldehyde, permeabilized for 15 min in 3% paraformaldehyde/0.5% Triton X-100, washed and quenched for 5 min in 0.1 M glycine, pH 7.1. Cells were then stained with primary antibody (1 : 300 anti-PTPe or 1 : 200 anti-FLAG M2) and subsequently with secondary antibody (CY3-or¯uorescein-conjugated anti rabbit or anti mouse IgG, Jackson Immunoresearch Laboratories, 1 : 400 dilution). Stained cells were examined with the aid of a Biorad model MRC 1024 confocal system and an Argon/ Krypton mixed gas laser, mounted on a Zeiss Axiovert microscope.
